Ticker Details
Lineage Cell Therapeutics, Inc.
IPO Date:	April 1, 1992
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$273.14M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.06 | 4.13%
Avg Daily Range (30 D):	$0.03 | 2.97%
Avg Daily Range (90 D):	$0.04 | 2.94%

Institutional Daily Volume
Avg Daily Volume:	.95M
Avg Daily Volume (30 D):	.87M
Avg Daily Volume (90 D):	1.08M

Trade Size
Avg Trade Size (Sh.):	287
Avg Trade Size (Sh.) (30 D):	188
Avg Trade Size (Sh.) (90 D):	207

Institutional Trades
Total Institutional Trades:	57
Avg Institutional Trade:	$3.74M
Avg Institutional Trade (30 D):	$.5M
Avg Institutional Trade (90 D):	$3.65M
Avg Institutional Trade Volume:	2.79M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.43M
Avg Closing Trade (30 D):	$21.06M
Avg Closing Trade (90 D):	$7.44M
Avg Closing Volume:	4.36M

News

May 20, 2026 @ 1:50 PM Cell-Based Therapies Poised to Disrupt Multi-Billi... Source: Market News Updates

Apr 10, 2026 @ 1:55 PM Biotechs Racing to Translate Longevity Science Int... Source: Usa News Group

Mar 18, 2026 @ 2:00 PM A Key "Master" Protein That Declines by Half After... Source: Equity-Insider.Com

Jan 29, 2026 @ 6:31 PM Longevity Biotech Stocks Surge as $27 Trillion Hea... Source: Prnewswire

Jul 30, 2025 @ 9:07 PM W.P. Carey (WPC) Q2 AFFO Jumps 9.4% Source: Jesterai

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.14	$.01	$-.02
Diluted EPS	$-.19	$-.03	$-.03
Revenue	$13.08M	$1.07M	$1.73M
Gross Profit
Net Income / Loss	$-32.11M	$1.54M	$-4.79M
Operating Income / Loss	$-26.85M	$-8.92M	$-7.59M
Cost of Revenue
Net Cash Flow	$-4.86M	$1.44M	$-4.85M
PE Ratio